Influence of hepatitis G virus (GB virus C) on the prognosis of HIV-infected women

International Journal of STD and AIDS

Volumn 22, Issue 4, 2011, Pages 209-213

  Campos, A F ^a   Tengan, F M ^a   Silva, S A A ^b   Levi, J E ^b  

^a Tobacco Treatment Outpatient Clinic   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antiretroviral therapy (art); Co infection; GB virus C; Hepatitis; HIV; Prevalence

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HEPATITIS E ANTIBODY; HEPATITIS E2 ANTIBODY; UNCLASSIFIED DRUG; VIRUS RNA;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; ESOPHAGUS CANDIDIASIS; FEMALE; HEPATITIS G VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MIXED INFECTION; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SEXUAL BEHAVIOR; SURVIVAL RATE; TOXOPLASMOSIS; TUBERCULOSIS; VIREMIA; VIRUS LOAD; VIRUS TRANSMISSION;

EID: 79955597684     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2011.010283     Document Type: Article

References (24)

1. Simons JN, Pilot-Matias TJ, Leary TP, et al. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci USA 1995;92:3401-3405
2. Linnen J, Wages J, Zhang-Keck ZY, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996;271:505-508
3. Leary TP, Muerhoff AS, Simons JN, et al. Sequence and genomic organization of GBV-C: a novel member of the Flaviviridae associated with human non-A-E hepatitis. J Med Virol 1996;48:60-67
4. Deinhardt F, Homes AW, Capps RB, Popper H. Studies on the transmission of human viral hepatitis to marmoset monkeys. I. Transmission of disease, serial passages and description of liver lesions. J Exp Med 1967;125:673-688
5. 0terminus of hepatitis G virus. J Viral Hepat 1997;4:293-302
6. Alter MJ, Gallagher M, Morris TT, et al. Acute non-A-E Hepatitis in the United States and the role of Hepatits G Virus Infection. N Engl J Med 1997;336:741-746
7. Mohr EL, Stapleton JT. GB virus type C interactions with HIV: the role of envelope glycoproteins. J Viral Hepatitis 2009;16:757-768
8. Ribeiro-dos-Santos G, Nishiya AS, Nascimento CM, et al. Prevalence of GB vi{dotless}rus C (hepatitis G vi{dotless}rus) and risk factors for infection in Sao Paulo, Brazil. Eur J Clin Microbiol Infect Dis 2002;21:438-443
9. Oliveira LA, Martins RM, Carneiro MA, et al. Prevalence and genotypes of GB vi{dotless}rus C/hepatitis G vi{dotless}rus among blood donors in Central Brazil. Mem Inst Oswaldo Cruz 2002;97:953-957
10. Levi JE, Contri DG, Lima LP, et al. High prevalence of GB vi{dotless}rus C/hepatitis G vi{dotless}rus RNA among Brazilian blood donors. Rev Inst Med Trop Sao Paulo 2003;45:75-78
11. Souza IE, Zhang W, Diaz RS, Chaloner K, Klinzman D, Stapleton JT. Effect of GB vi{dotless}rus C on response to antiretroviral therapy in HIV-infected Brazilians. HIV Med 2006;7:25-31
12. Tucker TJ, Smuts HE, Eedes C, et al. Evidence that the GBV-C/hepatitis G virus is primarily a lymphotropic virus. J Med Virol 2000;61:52-58
13. Toyoda H, Fukuda Y, Hayakawa T, Takamatsu J, Saito H. Effect of GB virus C/hepatitis G virus co-infection on the course of HIV infection in Hemophilia patients in Japan. J Acquir Immune Defic Syndr 1998;17:209-213
14. Heringlake S, Ockenga J, Tillmann HL, et al. GB virus C/hepatitis G virus Infection: a favorable prognostic factor in human immunodeficiency virus-infected patients? J Infect Dis 1998;177:1723-1726
15. Tillmann HL, Heiken H, Knapik-Botor A, et al. Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med 2001;345:715-724
16. Sabin CA, Devereux H, Kinson Z, et al. Effect of co-infection with hepatitis G virus on HIV disease progression in hemophilic men. J Acquir Immune Defic Syndr 1999;19:546-547
17. Nunnari G, Nigro L, Palermo F, et al. Slower progression of HIV-1 infection in persons with GB vi{dotless}rus C co-infection correlates with an intact T-helper 1 cytokine profile. Ann Intern Med 2003;139:26-30
18. Lefrere JJ, Roudot-Thoraval F, Morand-Joubert L, et al. Carriage of GB virus C/Hepatitis G virus RNA is associated with a slower immunologic, virologic and clinical progression of human immunodeficiency virus disease in coinfected persons. J Infect Dis 1999;179:783-789
19. Levi JE, Fink MCS, Canto CLM, et al. Human papillomavirus prevalence viral load and cervical intraepithelial neoplasia in HIV-infected women. Braz J Infect Dis 2002;6:129-134
20. Andonov A, Sauder C, Jacobsen H, Chaudhary R. Comparison of six sets of PCR primers from two different genomic regions for amplification of GB virus C/hepatitis G virus RNA. J Clin Microbiol 1998;36:286-289
21. a semanas epidemiologicas - Janeiro a Julho de 2008
22. Giret MTM, Silva TM, Sauer M, et al. GB vi{dotless}rus type C infection modulates T-cell activation independently of HIV-1 viral load. AIDS 2009;23:1-11
23. Polgreen PM, Xiang J, Chang Q, Stapleton JT. GB virus type C/hepatitis G virus: a non-pathogenic flavivirus associated with prolonged survival in HIV-infected individual. Microbes Infect 2003;5:1255-1261
24. Williams CF, Klinzman D, Yamashita TE, et al. Persistent GB virus C infection and survival in HIV infected men. N Engl J Med 2004;350:981-990